Assay News and Research

RSS

Chest CT shows COVID-19 damage to the lungs

A new study presents peer-reviewed cases of COVID-19 in order to ensure that the disease is diagnosed as rapidly as possible, and thus help prevent an overwhelming spike in infections in any one place during the course of the current pandemic. Much interest has been shown in the possibility of using chest X-rays, and computed tomography (CT) scans to screen for and diagnose patients with this illness, whether suspected or confirmed.

15 Mar 2020

New marker may predict whether NSCLC tumor is likely to metastasize

Non-small cell lung cancer (NSCLC) is the most commonly diagnosed cancer, and the leading cause of cancer death worldwide.

11 Mar 2020

Berkeley Lights Launches Cell Line Development 2.0 Workflow to Find Top Clones for Complex Antibody Therapeutics

The Opto™ Cell Line Development 2.0 workflow generates, in just days, the best production cell lines for complex antibody therapeutics.

From Bruker Cellular Analysis 10 Mar 2020

How effective is Gabapentin in alcohol use disorder?

A new study published in the journal JAMA Internal Medicine in March 2020 reports the striking efficacy of the drug gabapentin in helping people with alcohol use disorder (AUD) with their alcohol withdrawal symptoms.

9 Mar 2020

Sphingotec’s bio-ADM can reliably support physicians in identifying high-risk sepsis patients

Diagnostics company SphingoTec GmbH today reported on new data on the utility of endothelial function biomarker bioactive Adrenomedullin

5 Mar 2020

Novel drug to arrest antibiotic resistance by preventing micro-evolution

Desperate times need desperate measures. Accordingly, scientists, today published a new study in the journal Cell Host and Microbe in March 2020, showing that drugs that prevent the acquisition of DNA-borne antibiotic resistance traits from their surroundings by bacteria can stop mice from becoming resistant to the action of the antibiotics.

3 Mar 2020

New tool shows potential to predict developmental toxicity in humans with high accuracy

Recently published results from an evaluation of 1,065 chemical and drug substances using the devTOX quickPredict (devTOXqP) screening platform developed by Stemina Biomarker Discovery, Inc. demonstrated the platform's ability to predict developmental toxicity in humans with high accuracy using a cell-based test.

3 Mar 2020

Challenges for translating pharmacomicrobiomics to personalized medicine

A new Commentary identifies three actionable challenges for translating pharmacomicrobiomics to personalized medicine in 2020.

2 Mar 2020

Chest CT scan best for coronavirus diagnosis

A new study published in the journal Radiology in February 2020 reports that performing a CT (computed tomography) scan of the chest increases the diagnostic rate and outperforms the reverse-transcription polymerase chain reaction (RT-PCR) tests currently utilized. The researchers recommend using chest CT to screen symptomatic patients for COVID-19 infections rather than the less sensitive RT-PCR.

27 Feb 2020

Ortho Clinical Diagnostics announces launch and availability of VITROS XT 3400 Chemistry System

Ortho Clinical Diagnostics, a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions, today announced the launch and availability of the VITROS XT 3400 Chemistry System, which completes the company's VITROS XT Solutions, a comprehensive suite of solutions that help labs obtain consistently fast, accurate and reliable results.

From Ortho-Clinical Diagnostics, Inc. 27 Feb 2020

Advion’s parent company Bohui Innovation Biotechnology will acquire Interchim group

Advion Inc. today announces parent company Beijing Bohui Innovation Biotechnology Co., Ltd., has filed its intention to acquire Adchim SAS, the parent company of the Interchim group companies.

From Advion 27 Feb 2020

Promega's custom manufacturing capabilities support rapid development of Logix Smart COVID-19 Test

Promega Corporation is being recognized by Utah-based Co-Diagnostics, Inc.

From Promega Corporation 26 Feb 2020

New imaging tool to track cellular events that may initiate obesity-related conditions

A collaborative team of researchers at Utah State University and the University of Central Florida developed a tool to track cellular events that may lead to obesity-related conditions in people.

25 Feb 2020

Small molecules may open the door to new therapies for Duchenne muscular dystrophy

Researchers identified a group of small molecules that may open the door to developing new therapies for Duchenne muscular dystrophy, an as-yet-uncured disease that results in devastating muscle weakening and loss.

24 Feb 2020

Researchers explore whether plaque identifying toothpaste could prevent heart attack, stroke

For decades, researchers have suggested a link between oral health and inflammatory diseases affecting the entire body -- in particular, heart attacks and strokes.

24 Feb 2020

Isolating Single T-cells of Interest using an Optofluidic Platform

Researchers are in desperate need of single-cell analysis techniques and those that allow the isolation of high-value T-cells for research and development.

From Bruker Cellular Analysis 21 Feb 2020

Simple, portable test can detect poisonous mushrooms in minutes

A simple, portable test that can detect the deadliest of the mushroom poisons in minutes has been developed by Agricultural Research Service scientists and their colleagues.

19 Feb 2020

Supersensitive nanomaterials hold promise for DNA analysis and next-generation drugs

In 1900, German physician Paul Ehrlich came up with the notion of a "magic bullet." The basic idea is to inject a patient with smart particles capable of finding, recognizing, and treating a disease. Medicine has pursued the magic bullet ever since.

19 Feb 2020

New laser-driven technology to detect toxins and pathogenic E. coli in food samples

Researchers at Purdue University have been working to develop new technologies to help stop the spread of foodborne illnesses, which kill 3,000 people a year, by detecting them more efficiently.

16 Feb 2020

Sphere Fluidics expands operations to meet demand for large-scale supply of Pico-Surf surfactant

Sphere Fluidics, today announce investment in the production and supply of its proprietary biocompatible surfactant, Pico-Surf.

From Fluidic Sciences and Sphere Bio 13 Feb 2020